Qinzhou Wang
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Altered GABA and secondary bile acids in Guillain-Barré syndrome: association with gut dysbiosis.
Journal: Frontiers in immunology
Published: April 07, 2026
Sensitive life-stage periods and genetic susceptibility in the association between air pollution and ischaemic stroke risk: a Bayesian life-course analysis.
Journal: Journal of epidemiology and community health
Published: February 09, 2026
A combined approach of Interleukin-8 and magnetic resonance neurography to differentiate Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Journal: Journal of the neurological sciences
Published: September 25, 2025
Lumbosacral Plexus MR Neurography in Autoimmune Nodopathy: A Quantitative Analysis.
Journal: AJNR. American journal of neuroradiology
Published: June 02, 2025
Clinicopathological profiling and prognosis of idiopathic inflammatory myopathy overlapping with myasthenia gravis: a retrospective cohort study.
Journal: Journal of neurology
Published: May 16, 2025
Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: May 08, 2025
The Genetic Landscape of Acute Necrotizing Encephalopathy: Insights Into the Possible Pathogenesis.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: February 02, 2025
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes.
Journal: Therapeutic advances in neurological disorders
Published: November 07, 2024
Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis.
Journal: Therapeutic advances in neurological disorders
Published: October 18, 2024
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China.
Journal: Annals of clinical and translational neurology
Published: March 29, 2024
Last Updated: 09/26/2026